It is through this continuous antigen presentation and T‐cell activation that CD74+ B cells are able to maintain the TLS as a mature, functional structure, thereby effectively initiating and continuously driving antitumor immunity within the tumor. This evidence concerns the gene CD74 and neoplasm.